- Location
neuropathic pain
"-
Green LED Light May Be a Solution for Chronic Pain Relief
Mar 3, 2017A study by UA researchers revealed that rats with neuropathic pain that were bathed in green LED showed more tolerance for thermal and tactile stimulus. A clinical trial involving people suffering from fibromyalgia is underway. It wasn't ...
Tags: LED, green light
-
An Estimated 7.8 Million People Have Their Lives Blighted by Chronic Pain
Jan 20, 2014IN the UK alone, an estimated 7.8 million people have their lives blighted by chronic pain, and 44 per cent are failing to receive an accurate diagnosis and appropriate treatment. Now, a University of Huddersfield scientist, backed by ...
Tags: Prestigious Clulow Award, University of Huddersfield Scientist
-
Alzheon Announced The Launch of The Company,The Securing of Initial Private Financing
Oct 28, 2013Alzheon announced the launch of the company, the securing of initial private financing, and the signing of an exclusive license agreement to a novel clinical drug candidate for Alzheimer’s disease, a family of analogs, and a drug ...
Tags: Alzheon, Alzheimer's Disease
-
ICAP Patent Has Announced for Sale a Patented Multi-Purpose Topical Analgesic Cream
Dec 19, 2012ICAP Patent Brokerage,a provider of post trade risk and information services,has announced for sale a patented multi-purpose topical analgesic cream,designed for treating arthritis,other chronic pain syndromes as well as muscle ...
Tags: ICAP, analgesic cream, MyoRX
-
The European Union Has Granted CE Mark Approval to Insightec's Transcranial
Dec 7, 2012The European Union has granted CE mark approval to InSightec's transcranial focused ultrasound system for the treatment of essential tremor, tremor dominant Parkinson's disease and neuropathic pain. The non-invasive ExAblate Neuro ...
Tags: transcranial focused ultrasound system, Parkinson's disease
-
FDA Has Granted Approval to Lupin for Generic Lyrica (Pregabalin) Capsules
Dec 7, 2012The US Food and Drug Administration (FDA) has granted approval to Lupin Pharmaceuticals to market a generic version of CP Pharmaceuticals' Lyrica (Pregabalin) capsules. Lupin's generic equivalent of Lyrica capsules are manufactured as ...
Tags: FDA, Lupin Pharmaceuticals, lyrica capsules
-
USPTO Has Issued Notice of Allowance for Avanir Pharmaceuticals' Patent Application
Dec 4, 2012The United States Patent and Trademark Office (USPTO) has issued notice of allowance for Avanir Pharmaceuticals' patent application covering Nuedexta. The patent application entitled, Pharmaceutical Compositions Comprising ...
Tags: USPTO, patent application, nuedexta, pseudobulbar affect
-
Nectid Has Initiated Clinical Development of Agomelatine for Autism and Pain Indications
Nov 29, 2012Nectid, a drug discovery company, has initiated clinical development of agomelatine for autism and pain indications in the US. Agomelatine, a melatonergic agonist (MT1 and MT2 receptors) and 5-HT2C antagonist, is approved for the ...
-
Eli Lilly Meets FDA Requirements for Pediatric Exclusivity for Cymbalta
Jul 9, 2012Eli Lilly and Company has met the United States Food and Drug Administration (FDA) requirements for pediatric exclusivity for Cymbalta (duloxetine HCl), which is available in 20-mg, 30-mg, and 60-mg capsules. As part of the approval, ...
-
Pfizer Lyrica for Neuropathic Pain Management Was Approved by FDA
Jun 22, 2012The US Food and Drug Administration (FDA) has approved Pfizer's Lyrica (pregabalin) capsules CV for the management of neuropathic pain associated with spinal cord injury based on priority review. The FDA approval is based on two ...
Tags: FDA approval, neuropathic pain, Lyrica, clinical researh
-
JPO Has Issued a Patent to Neurogesx for NGX-1998
Jun 19, 2012The Japanese Patent Office (JPO) has issued a patent to NeurogesX for NGX-1998, a topically applied liquid formulation of prescription strength capsaicin designed to treat pain associated with neuropathic pain conditions. The patent is ...
-
BiolineRx Has Received Two Notices of Allowance From Uspto for Treating Neuropathic Pain
Jun 6, 2012BioLineRx has received two notices of allowance from USPTO for BL-1021, an orally available small molecule for treating neuropathic pain. The first notice of allowance is issued for patent application claiming BL-1021's composition. Once ...
Tags: BL-1021, neuropathic pain, USPTO allowance
-
$27.5m Has Been Invested by Ge Healthcare in Insightec
May 29, 2012InSightec Image Guided Treatment, a subsidiary of Elbit Medical Technologies, has signed a memorandum of understanding (MOU) with GE Healthcare. Under the MOU, GE Healthcare will invest $27.5m in Insightec, reports globes.co.il. ...
-
EpiCept Has Received Fast Track Designation for AmiKet From The FDA
Apr 10, 2012EpiCept has received fast track designation for AmiKet (amitriptyline 4%, ketamine 2% cream) from the US Food and Drug Administration (FDA). AmiKet is indicated for the treatment of neuropathic pain associated with ...
Tags: FDA, fast track designation, treatment of neuropathic pain
Related Products
-
Cold Laser Physical Therapy Instrument with 2 Probes for Neuropathic Pain, Rheumatic Pain, Inflammation
-
Luxmaster Physio Physical Therapy Machines 635mn 405nm Red Laser Pain Treatment Rehabilitation Neuropathic Pain Relief Luxmaster
-
Wholesale Chemical Raw Material Powder Gabapentin, Best Quality, 99%Purity, CAS 60142 96 3 Neurontin Gabapentin for Antidepressent Neuropathic Pain
-
Wholesale Chemical Raw Material Powder Gabapentin, Top Quality, 99%Purity, CAS 60142-96-3 Neurontin for Antidepressent Neuropathic Pain Safe Delievey Gabapentin
-
Pharmaceutical Ingredients High Purity Gabapentin CAS 60142-96-3 Antidepressent Neuropathic Pain Raw Powder
-
High Purity Clonidine Hydrochloride CAS 4205-91-8 Clonidine Powder for Neuropathic Pain
